Ikarian Capital’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$2.24M Buy
2023
Q4
Sell
2023
Q3
$1.37M Buy
2023
Q2
$1.26M Hold
2023
Q1
$1.1M Buy
2022
Q2
Sell
2022
Q1
$586K Buy
2021
Q4
$484K Sell
2021
Q3
$1.69M Sell
2021
Q2
$2.32M Sell
2021
Q1
$7.63M Sell
2020
Q4
$20.2M Sell
2020
Q3
$15.6M Buy
2020
Q2
$13.5M Buy
2020
Q1
$7.24M Buy
2019
Q4
$3.78M Buy